UpdatesGeneral Updates
Nureca delivered robust Q3 FY26. Revenue grew 27% YoY to INR 54.0 Cr, EBITDA surged 314% to INR 5.4 Cr, and PAT climbed 233% to INR 3.7 Cr.
Nureca LimitedNURECA · Filed with the exchange
New products launched, and Dr Trust 360 app users grew.
Manufacturing site development is delayed.
No comments yet. Be the first.